Acute and sub-chronic toxicity study of recombinant bovine interferon alpha in rodents

Author:

Yu Hai-Yang1,Gao Dong-Mei2,Zhou Wei3,Xia Bing-Bing3,He Zhi-Yuan3,Wu Bo3,Jiang Min-Zhi3,Wang Ming-Li13,Zhao Jun134

Affiliation:

1. Department of Microbiology, Anhui Medical University, Hefei , Anhui Province , , P.R. China

2. Department of Clinical Laboratory, Third Affiliated Hospital of Anhui Medical University, Hefei , Anhui Province , , P.R. China

3. Wuhu Interferon Bio-products Industry Research Institute Co., Ltd, Wuhu , Anhui Province , , P.R. China

4. Wuhu Overseas Students Pioneer Park, Wuhu , Anhui Province , , P.R. China

Abstract

Abstract Introduction Recombinant bovine interferon alpha (rBoIFN-α) has been demonstrated to have antiviral activity. However, no conduct of acute or chronic toxicity tests has been reported. Material and Methods Specific pathogen-free Sprague Dawley rats were administered doses at different concentrations through intraperitoneal or intravenous injection. After the administration (single for an acute toxicity test over 14 days or daily for a sub-chronic toxicity test over 30 days), the rats’ behaviour and other indicators and the degree of toxic reaction were continuously monitored. Blood was collected for haematological and serum biochemical examinations. At the end of the experiments, the rats were sacrificed for necropsy and histopathological tissue analysis. Results The external performance, behaviour characteristics, and changes in body temperature and body weight of the rats in each subgroup were comparable to the normal control subgroup. Except for a few cases, there were no lesions in the viscera’s pathological structures, and the blood parameters and biochemical indicators were not noticeably different from those of the control subgroup. Conclusion This study suggests that rBoIFN-α seems to be safe for rats, and its use may foster the development of the cattle industry in China by protecting livestock health.

Publisher

Walter de Gruyter GmbH

Subject

General Veterinary

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3